A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD

por Crim, Courtney, Gotfried, Mark, Spangenthal, Selwyn, Watkins, Michael, Emmett, Amanda, Crawford, Catriona, Baidoo, Charlotte, Castro-Santamaria, Ramiro
Publicado 2020

Baseline Subject Characteristics Predictive of Compliance with Study-Mandated Prostate Biopsy in Men at Risk of Prostate Cancer: Results from REDUCE

por Fischer, Sean, Sun, Stephanie, Howard, Lauren E., Moreira, Daniel M., Castro-Santamaria, Ramiro, Andriole, Gerald L., Vidal, Adriana C., Freedland, Stephen J.
Publicado 2016

Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study

por Jamnagerwalla, Juzar, Howard, Lauren E., Allott, Emma H., Vidal, Adriana C., Moreira, Daniel M., Castro-Santamaria, Ramiro, Andriole, Gerald L., Freeman, Michael R., Freedland, Stephen J.
Publicado 2017

Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD

por Crim, Courtney, Watkins, Michael L, Bateman, Eric D, Feldman, Gregory J, Schenkenberger, Isabelle, Kerwin, Edward M, Crawford, Catriona, Pudi, Krishna, Ho, Shuyen, Baidoo, Charlotte, Castro-Santamaria, Ramiro
Publicado 2019

Racial differences in prostate inflammation: results from the REDUCE study

por Vidal, Adriana C., Chen, Zinan, Howard, Lauren E., Moreira, Daniel M., Castro-Santamaria, Ramiro, Andriole, Gerald L., Taioli, Emanuela, Fowke, Jay H., Knudsen, Beatrice, Drake, Charles G., Nickel, J. Curtis, Freedland, Stephen J.
Publicado 2016